Soleno Therapeutics, Inc. (NASDAQ:SLNO) traded at $2.08 at last check on Monday, Jun 29, making an upward move of 13.04% on its previous day’s price.

Looking at the stock we see that its previous close was $1.84 and the beta (5Y monthly) reads 0.48 with the day’s price range being $1.8600 – 2.0900. In terms of its 52-week price range, SLNO has a high of $4.39 and a low of $1.18. The company’s stock has gained about -38.1% over that past 30 days.

On the other hand, looking at the outlook for the SLNO stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Sell.

Let’s briefly compare Soleno (SLNO) stock to its peers. We find that today’s price change of +13.04% and -25.71% over the past 12 months for SLNO competes that of Zoetis Inc Cl A (ZTS), which has seen its stock price fall -0.51% in the latest trading session and is +16.29% over the last one year. Another of its peers Takeda Pharmaceutical Co. Ltd (TAK) has dropped -1.25% today, and is +2.32% up over the past year, while Grifols S.A. (GRFS) is also up 13.04% yet its price remains in the red at -25.71% over the same period. Zoetis has a P/E ratio of 39.26 compared to Soleno’s 0 and Takeda’s 22.32. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.

Coming back to Soleno Therapeutics, Inc. (NASDAQ:SLNO), we note that the average 3-month trading volume was 783.27 Million, while that of the preceding 10-day period stands at 2.52 Million. Current shares outstanding are 44.71 Million.

According to data from Thomson Reuters, insiders hold 13.82% of the company’s shares while institutions hold 53.15%. The data shows that short shares as of June 14, 2020, stood at 1.81 Million at a short ratio of 1.41. This represents a 4.06% Short interest in Shares outstanding on June 14, 2020. Shares short dropped in June from the previous month at 423.17 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -29.25% down in year-to-date price movement.